Loading...

A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression

OBJECTIVE: Patients (30–50%) with non-psychotic major depression will not respond despite an adequate trial of antidepressant medication. This study evaluated risperidone as an augmenting agent for patients who failed or only partially responded to an adequate trial of an antidepressant medication....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Keitner, Gabor I., Garlow, Steven J., Ryan, Christine E., Ninan, Philip T., Solomon, David A., Nemeroff, Charles B., Keller, Martin B.
Format: Artigo
Sprog:Inglês
Udgivet: 2008
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3685867/
https://ncbi.nlm.nih.gov/pubmed/18586273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpsychires.2008.05.003
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!